XOMA Royalty (XOMA) Return on Capital Employed Growth (5y) (2016 - 2026)
XOMA Royalty (XOMA) Return on Capital Employed Growth (5y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
XOMA Royalty |
5.48 Mn |
-60.60 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-1,049.00 |
| Dec 31, 2025 |
-1,046.00 |
| Sep 30, 2025 |
2,167.00 |
| Jun 30, 2025 |
629.00 |
| Mar 31, 2025 |
-8.00 |
| Dec 31, 2024 |
-1,546.00 |
| Sep 30, 2024 |
-2,023.00 |
| Jun 30, 2024 |
-252.00 |
| Mar 31, 2024 |
-268.00 |
| Dec 31, 2023 |
801.00 |
| Sep 30, 2023 |
1,602.00 |
| Jun 30, 2023 |
-6,917.00 |
| Mar 31, 2023 |
-7,976.00 |
| Dec 31, 2022 |
-5,545.00 |
| Sep 30, 2022 |
627.00 |
| Jun 30, 2022 |
238,121.00 |
| Mar 31, 2022 |
175,591.00 |
| Dec 31, 2021 |
-104,440.00 |
| Sep 30, 2021 |
18,701.00 |
| Jun 30, 2021 |
13,580.00 |
